Cargando…
Efficacy and safety of intravenous OPC‐61815 compared with oral tolvaptan in patients with congestive heart failure
AIMS: This multicentre, randomized, controlled, double‐blind, parallel‐group Phase III study was conducted to confirm the non‐inferiority of OPC‐61815 (tolvaptan sodium phosphate) intravenous injections to oral tolvaptan tablets in patients with congestive heart failure and volume overload despite r...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715865/ https://www.ncbi.nlm.nih.gov/pubmed/35794067 http://dx.doi.org/10.1002/ehf2.14021 |